Authorized purpose: AI-Rad Companion Organs RT VA70 automatically contours predefined structures, including known diagnosed brain metastases, on DICOM CT and MR images for radiation therapy planning; qualified users must review, edit and accept contours in suitable planning or contouring software, and the device is not intended for diagnosis.
Clinical role
Radiotherapy structure segmentation and contouring support
Images and patients
Radiotherapy Planning Imaging · Head/neck, thorax, abdomen, pelvis; MR brain and male pelvis
Key limitation
Keep in mind: Not intended for diagnosis. Brain metastases must already be known/diagnosed. Automatically transferred contours still require review and, where necessary, editing in a TPS or interactive contouring application before treatment-planning use. Models are locked and cannot be modified by users.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: AI-Rad Companion Organs RT VA70 automatically contours predefined structures, including known diagnosed brain metastases, on DICOM CT and MR images for radiation therapy planning; qualified users must review, edit and accept contours in suitable planning or contouring software, and the device is not intended for diagnosis.
Which images or clinical context are in scope?Modality: Radiotherapy Planning Imaging Anatomy or clinical context: Head/neck, thorax, abdomen, pelvis; MR brain and male pelvis Input: DICOM CT series for head/neck, thorax, abdomen and pelvis; MR series for brain and male-pelvis structures, including the labeled brain-metastasis workflow.
Who uses it?Intended users: Qualified and trained medical professionals
What does the software produce?Output: DICOM Radiotherapy Structure Set (RTSS) contours; a results preview supports confirmation or rejection before transfer to a configured target node.
What is its most important limitation?Key limitation: Not intended for diagnosis. Brain metastases must already be known/diagnosed. Automatically transferred contours still require review and, where necessary, editing in a TPS or interactive contouring application before treatment-planning use. Models are locked and cannot be modified by users.
Clinical takeaway. Clinical role: AI-Rad Companion Organs RT VA70 automatically contours predefined structures, including known diagnosed brain metastases, on DICOM CT and MR images for radiation therapy planning; qualified users must review, edit and accept contours in suitable planning or contouring software, and the device is not intended for diagnosis.
Evidence takeaway. Evidence from the reviewed source record: Exact-submission validation supports clinician-reviewed segmentation. Older-version independent feasibility evidence does not establish VA70A clinical outcomes or local time savings.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
AI-Rad Companion Organs RT VA70 automatically contours predefined structures, including known diagnosed brain metastases, on DICOM CT and MR images for radiation therapy planning; qualified users must review, edit and accept contours in suitable planning or contouring software, and the device is not intended for diagnosis.
DICOM CT series for head/neck, thorax, abdomen and pelvis; MR series for brain and male-pelvis structures, including the labeled brain-metastasis workflow.
Not intended for diagnosis. Brain metastases must already be known/diagnosed. Automatically transferred contours still require review and, where necessary, editing in a TPS or interactive contouring application before treatment-planning use. Models are locked and cannot be modified by users.
Exact-submission validation supports clinician-reviewed segmentation. Older-version independent feasibility evidence does not establish VA70A clinical outcomes or local time savings.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
Exact-submission validation supports clinician-reviewed segmentation. Older-version independent feasibility evidence does not establish VA70A clinical outcomes or local time savings.
No single transferable diagnostic sensitivity is established by the reviewed contouring evaluations; organ- and algorithm-specific validation must be consulted.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-05
No single diagnostic specificity for VA70A is established in this review.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K252548 VA70A software and contouring validation
DesignManufacturer retrospective image-based algorithm validation against manual annotations, literature/cleared-device references and VA60A, plus software verification
PopulationCT datasets acquired for radiotherapy planning across multiple continents; separate MR organ and metastasis datasets
Scopeexact submission
Tested versionAI-Rad Companion Organs RT SW VA70A
IndependenceSponsor or vendor study
K252548
CT evaluation reports N=469; MR datasets have different denominators. No clinical tests were conducted for the modifications; no aggregate diagnostic accuracy is inferred.
Feasibility evaluation of novel AI-based deep-learning contouring algorithm for radiotherapy
DesignRetrospective feasibility comparison of automated and three independent human contour sets, with expert ratings and geometric assessment
Population30 CT patients: ten pelvis, ten thorax and ten head/neck
Scopeproduct family
Tested versionAI-Rad Companion Organs RT VA30A
Samplen=30
IndependenceIndependence not established
PMID 37464581 · DOI 10.1002/acm2.14090
Abstract and conflict statement reviewed; authors declare no conflicts. Funding/support independence was not established. Agreement and editing requirements varied by organ. This is older-version context, not K252548 performance.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM CT series for head/neck, thorax, abdomen and pelvis; MR series for brain and male-pelvis structures, including the labeled brain-metastasis workflow.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: DICOM CT/MR input and RTSS output to a configurable DICOM node, typically a TPS or contouring application; optional direct transfer without manual confirmation is described.
Scope: Exact FDA submission. This establishes format and workflow support, not tested interoperability with every local TPS.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed summary establishes processing and target-node routing, but does not establish the current site's hosting model, region, sizing, retention or service commitments.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-05 ·
Returned objects
Source context, not route validation: DICOM Radiotherapy Structure Set (RTSS) contours; a results preview supports confirmation or rejection before transfer to a configured target node.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: DICOM Radiotherapy Structure Set (RTSS) contours; a results preview supports confirmation or rejection before transfer to a configured target node.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
DICOM CT/MR input and RTSS output to a configurable DICOM node, typically a TPS or contouring application; optional direct transfer without manual confirmation is described.
Exact FDA submission
Checked 2026-09-05
This establishes format and workflow support, not tested interoperability with every local TPS.
Siemens Healthineers' corporate cybersecurity page states a Secure Development Lifecycle addressing pre-market and post-market phases for products under development and a range of existing offerings; a Cybersecurity Management Service maintaining a product security inventory (over 1,000 product versions and over 21,000 monitored software components) with security whitepapers, SBOMs and vulnerability assessments available to customers via teamplay Fleet; incident and vulnerability management channels; and that Siemens Healthineers AG maintains an independent certification of its global Cybersecurity Management System to ISO/IEC 27001:2022 extended by ISO/IEC 27701:2019, with the certificate referenced to the SGS directory. Vendor statement; no certificate or report was read.
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: Siemens Healthineers' own corporate-info page names Siemens Medical Solutions USA, Inc. (Malvern, PA), and its 2024 governance press release states Siemens Healthcare GmbH's business was transferred to Siemens Healthineers AG. Corporate program statement; exact-release scope is not established.
Siemens Healthineers' cybersecurity page states that its Cybersecurity Management Service maintains a product security inventory of over 1,000 product versions and over 21,000 monitored software components, with security whitepapers, SBOMs and vulnerability assessments delivered via teamplay Fleet, and that it operates incident and vulnerability management.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The page names Siemens Healthineers generally and does not scope these commitments to any specific product release; exact-release scope is not established.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-05Last searched
19Fields reviewed
11Source classes checked
8Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
All eight stored titles/dates were screened. PMID 37464581 was additionally read live and retained as VA30A family context. The other seven metadata records do not establish VA70A/K252548 linkage and are not promoted; full-text applicability remains unresolved. No stored trial candidates. The current discovery snapshot contains 8 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, literature index, trial registry, fda decision summary, vendor product page, peer reviewed literature, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-05 - Exact FDA submission
No exact VA70A amount, license unit, term or implementation/support price was established from the reviewed material.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Siemens Healthineers AI-Rad Companion reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.
Deployment: Not verified - checked 2026-09-05 - Exact FDA submission
The reviewed summary establishes processing and target-node routing, but does not establish the current site's hosting model, region, sizing, retention or service commitments.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-05 - Exact FDA submission
Qualified trained users are required, but the VA70A onboarding curriculum, competency sign-off and support terms were not established.
Authorized purpose: DeepBT Detector-Plus provides initial gross-tumor-volume contours on T1-weighted contrast-enhanced and optional T2-weighted MR images for radiation-treatment planning in adults with the labeled brain tumors.
Modality
Radiotherapy Planning Imaging
Anatomy
Brain tumors, including metastases, meningiomas, and acoustic neuromas
Authorized purpose: AutoContour Model RADAC V5 assists radiation treatment planners with contouring and reviewing structures in medical images for radiation therapy treatment planning. It produces initial machine-learning contours for user review and modification; it does not independently approve a contour or treatment plan.
Authorized purpose: syngo.via RT Image Suite VC10 provides three-dimensional and four-dimensional multimodality visualization, registration, fusion, contouring, and planning support for radiation-treatment preparation.
Modality
Radiotherapy Planning Imaging
Anatomy
Brain, pelvis, thorax, abdomen, targets, organs at risk, and moving tumors or organs
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.